With rapid advancements in the management of lung cancer, new questions and challenges undoubtedly arise. Here, James Spicer, PhD, FRCP, of Guy’s and St Thomas’ NHS Foundation Trust, London, UK, discusses these challenges. Prof. Spicer emphasizes that while previously a distant thought, the long-term control of lung cancer may now be an emerging reality, which clinicians will need to address. In addition, he highlights the increasing complexity of trials containing many agents with an exponential number of combination possibilities, meaning selectivity and optimal trial design is essential. This video was recorded at the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland.
Future challenges in lung cancer: long-term control and trial selectivity
